Top Artificial Intelligence-Based Healthcare Mobile Apps and Their Use Cases

Articles

CAR-T Cell Therapy aka Miraculous Technology: M...

Chimeric antigen receptor T-cell (CAR T) therapies are shown to have transformative potential as a new type of cancer treatment that utilizes the immune system to fight the disease. It involves the...

Dec 13, 2021

contract-organizations-impacting-pharma-development-and-manufacturing
Contract Organizations Impacting Pharma Development and Manufacturing

Contract Development and Manufacturing Organisation (CDMO) is a term for organizations providing extensive services and solutions to the pharmaceutical and biotech industry starting from the drug development process to packaging of the product. These companies deliver a broad range of services, such as clinical res...

Find More
ash-2021-annual-meeting-coverage
Major Highlights of ASH 2021 Annual Meeting: Stay abreast of the fresh developments!!

Blood cancers have seen tremendous advancements in the past few years due to the dedication of researchers pulling out all the stops to churn out therapeutic innovations intended to be of service to suffering patients. These experimentations and their upshots are always brought to us through various platforms, the ...

Find More
Novel-Upcoming-Osteoporosis-Drugs-Market
What All You Need to Know About Evolving Osteoporosis Therapeutic Landscape?

Osteoporosis can be characterized by a decrease in the density of bone, resulting in fragile bones which can decrease its strength. Osteoporosis leads to an extent of abnormally porous bones that are observed to be very compressible, just like a sponge. This skeleton disorder cripples the bones and consequently res...

Find More

More Views & Analysis

tigit-Inhibitor-landscape
T-cell Immunoglobulin and ITIM domain (TIGIT) Inhibitor: An Insight into the Pipeline Development Activities, Major Collaborations, and Advancements

T-cell immunoreceptor with Ig and ITIM domains (TIGIT) is a relatively new immunological checkpoint that has been studied as a potential immunotherapeutic target. TIGIT is a transmembrane glycoprotein receptor containing an Ig-like V-type domain in its cytoplasmic domain and an ITIM in its extracellular domain. It'...

Find More

biosimilar-market-outlook
Analyzing the Growth of the Biosimilar Market Through Years

The expiration of many biologic drugs patents has sparked biosimilar development and boosted the biosimilar market growth. Biosimilars are alternative versions of innovator biologic drugs. These are biological products that are similar replicas of the biopharmaceuticals that inspired them. Biosimilars are sometimes...

Find More

mobile-apps-for-mental-health
Plotting the Extensive Demand of Mobile Apps for Mental Health

Mental health services in the new technology-driven world offer so many options. Many of these options are accessible via intuitive apps that are designed to streamline the mental health journey and take most of the guesswork out of finding the expert attention. Most of these apps allow to access the features at an...

Find More

Neuromodulation-Devices-Migraine
Neuromodulation Devices Observed to Reshape the Migraine Treatment Dynamics

Migraine is the most commonly encountered disabling disorder that can be featured as attacks of severe, unilateral, and a pulsating form of headache composed of symptoms such as photophobia, phonophobia, nausea, vomiting, and cutaneous allodynia. As per the Migraine Research Foundation 2021, Migraine is considered ...

Find More

Avrobios-Gene-Therapy-for-Cystinosis
Avrobio’s Gene Therapy for Cystinosis Treatment: A New Hope to Overcome the Existing Medical Unmet Needs

Cystinosis is a genetic condition that causes the buildup of the amino acid "cystine" in the cells of the body is known as cystinosis. Due to the excessive accumulation of cystine in various cells, organs, tissues, including the kidneys, eyes, liver, thyroid, muscles, pancreas, brain, and white blood cells of the b...

Find More

follicular-lymphoma-treatment-scenario
Diverse Pipeline Therapies to Glide the Follicular Lymphoma Treatment Market

Follicular Lymphoma is the second most widespread non-Hodgkin lymphoma subtype, accounting for roughly 20% of all NHL cases. It is a slow-growing (low-grade) NHL that develops from B cells. It is called follicular lymphoma because the abnormal B cells usually develop in clumps called ‘follicles’ inside lymph nodes....

Find More

IPSCs have enormous applications in the field of regenerative medicine, disease modelling, and drug .....

Find More

Immunity is a major concern in the present times, and consumers have increased their focus on boosti.....

Find More

Dementia is one of the major chronic and progressive syndrome caused by a number of different condit.....

Find More

Doctors and scientists have recognized that traditional, complementary and alternative therapies hav.....

Find More

Wearable technology has been gaining momentum for the last few years as an effect of the fourth indu.....

Find More

A complex genetic condition, Prader-Willi syndrome (PWS) is a result of the loss of the functioning .....

Find More